SPECIFIC PHARMA A/S: Financial statements 2014
CVR: 33161395
Source: annual report 2014, Danish Business Authority
01/02/2013 – 31/01/2014
SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 137,766,000 and a net result of DKK 18,713,000 compared with DKK 10,587,627 the year before. That is an increase of 129.2% compared with the year before. The profit margin was 13.6%. Equity in the 2014 report amounted to DKK 37,299,000. The solvency ratio was 71%.
- Revenue
- DKK 137,766,000
- Gross Profit
- DKK 30,260,000
- Profit/Loss
- DKK 18,713,000
- Equity
- DKK 37,299,000
- Total Assets
- DKK 52,521,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 137.8 mio. | 30.3 mio. | 18.7 mio. | 37.3 mio. | - |
| 2013 | 60.1 mio. | 16.8 mio. | 10.6 mio. | 18.6 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of November 1, 2014, Per Bornhøft Hansen has joined the board of directors of SPECIFIC PHARMA A/S.
As of November 1, 2014, Henrik Kaastrup has joined the board of directors of SPECIFIC PHARMA A/S.
As of November 1, 2014, Samia Sofie Kappe is registered as adm. dir. of SPECIFIC PHARMA A/S.
As of November 1, 2014, Henrik Kaastrup has stepped down as adm. dir. of SPECIFIC PHARMA A/S.
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of SPECIFIC PHARMA A/S.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of SPECIFIC PHARMA A/S.
As of September 15, 2014, NOMECO A/S is registered as an owner of SPECIFIC PHARMA A/S with an ownership share of 100%.
As of July 4, 2014, Henrik Kaastrup is registered as adm. dir. of SPECIFIC PHARMA A/S.
As of June 29, 2014, Ulf Blangsted Henriksen has stepped down as adm. dir. of SPECIFIC PHARMA A/S.
As of April 28, 2014, Kristine Sakstrup Haag has joined the board of directors of SPECIFIC PHARMA A/S.
About SPECIFIC PHARMA A/S
SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The board consists of Kristine Sakstrup Haag (chair), Henrik Kaastrup, Kasper Casparij Yde and Ken Rasmussen. The company is owned by NOMECO A/S. The company has 24 employees (2018). In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity in the 2026 report amounted to DKK 98,645,000.